Several of our experts have identified the healthcare sector as a powerful profit play. But where should you invest within the industry? Which Big Pharma plays offer the right combination of growth and income? And where can you strike it rich in the ever-shifting biotechnology space? Find out from our sector experts in this enlightening and actionable panel discussion.
- Obesity/diabetes drugs are the biggest market in history
- The bidding war for MTSR, with GLP-1 King Novo failing twice to outbid Pfizer, also shows the value for second-generation obesity treatments
- John will show you which companies have drugs with novel mechanisms of action – and could be huge winners as a result